Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model

Abstract

The rate of infusion reactions in children receiving infliximab is similar to that in adults. Female gender, immunosuppressive use for less than 4 months and prior infusion reactions may be risk factors for subsequent infusion reactions in children.